Presentation TCT 2017 Complex PCI in Triple Vessel Disease: Do the Economics Make Sense? Presenter: Fernando Alfonso, Patrick W. Serruys, Hemal Gada October 30, 2017
Presentation TCT 2017 PCI vs. CABG: The Impact of Medication Adherence on Comparative Outcomes Presenter: Fernando Alfonso, Patrick W. Serruys, Paul Kurlansky October 30, 2017
Presentation TCT 2017 SYNTAX II: Contemporary Outcomes of PCI in 3VD Presenter: Fernando Alfonso, Patrick W. Serruys, Adrian P. Banning October 30, 2017
Presentation TCT 2017 Do We Have Enough Data to Make PCI vs CABG Decisions in Complex CAD Using FFR? Presenter: Fernando Alfonso, Patrick W. Serruys, William F. Fearon October 30, 2017
Presentation TCT 2017 Controversial Position Statement: Polymer-Free DES Provide the Optimal Balance of Safety and Efficacy (and Will Improve Most in the Future)! Presenter: Giulio G. Stefanini, Stephan Windecker, Philip M. Urban October 30, 2017
Presentation TCT 2017 Metallic DES Are Different! How I Choose Stent Type to Match the Lesion and Patient (From 30 Years of Experience) Presenter: Giulio G. Stefanini, Stephan Windecker, Antonio Colombo October 30, 2017
Presentation TCT 2017 Are All Contemporary DES Comparable? Lessons From the SCAAR Registry Presenter: Giulio G. Stefanini, Stephan Windecker, Stefan K. James October 30, 2017
Presentation TCT 2017 Are All Contemporary DES Comparable? Lessons From the COMPARE Trials Presenter: Giulio G. Stefanini, Stephan Windecker, Elvin Kedhi October 30, 2017
Presentation TCT 2017 Are All Contemporary DES Comparable? Lessons From the TWENTE Trials Presenter: Giulio G. Stefanini, Stephan Windecker, Clemens von Birgelen October 30, 2017
Presentation TCT 2017 Are All Contemporary DES Comparable? Lessons From the SORT-OUT Trials Presenter: Giulio G. Stefanini, Stephan Windecker, Evald H. Christiansen October 30, 2017
Presentation TCT 2017 Are There Meaningful Differences Between Current Durable Polymer-Based vs Bioabsorbable Polymer-Based vs Polymer-Free Metallic DES? Pathologic Insights Presenter: Giulio G. Stefanini, Stephan Windecker, Renu Virmani October 30, 2017
Presentation TCT 2017 Mortality and Stroke After PCI vs CABG In Left Main and 3VD: An Individual Patient Data Meta-analysis Presenter: Dean J. Kereiakes, Spencer B. King III, A. Pieter Kappetein October 30, 2017
Presentation TCT 2017 Influence of Diversity: Should Sex, Race, and Ethnicity Affect Revascularization Decisions? Does It? Presenter: Dean J. Kereiakes, Spencer B. King III, Roxana Mehran October 30, 2017
Presentation TCT 2017 Impact of Mandatory Stent Price Controls 2: My New Insights From Inside Industry Presenter: Dean J. Kereiakes, Spencer B. King III, Ian T. Meredith October 30, 2017
Presentation TCT 2017 Impact of Mandatory Stent Price Controls 1: Physician Perspectives Presenter: Dean J. Kereiakes, Spencer B. King III, Upendra Kaul October 30, 2017
Presentation TCT 2017 Impact of AUC and Public Reporting: Is PCI Now More Appropriate? Presenter: Dean J. Kereiakes, Spencer B. King III, Michael A. Kutcher October 30, 2017
Presentation TCT 2017 Metallic DES: What Can We Expect From New Drugs, Polymers, and Metals? Have We Reached the Limit of Iterative Development? Presenter: Dean J. Kereiakes, Spencer B. King III, Elazer R. Edelman October 30, 2017
Presentation TCT 2017 New Insights Into Neoatherosclerosis and Other Causes of Metallic Stent Thrombosis: Will the Most Dreaded Complication Always Be With Us? Presenter: Dean J. Kereiakes, Spencer B. King III, Aloke V. Finn October 30, 2017
Presentation TCT 2017 Is There a Need for Dedicated Bifurcation Stents (Bare Metal or Drug-Eluting)? Presenter: Alaide Chieffo, Jeffrey W. Moses, Martin B. Leon October 30, 2017
Presentation TCT 2017 Very Late Stent Failures and Non-Stent Related Events: Insights Into Improving Event-Free Survival Presenter: Dean J. Kereiakes, Spencer B. King III, Lorenz Raber October 30, 2017